2015
$300M
from 10 investors over 10 rounds
Tizona Therapeutics, Inc. raised $300M on July 21, 2020
Investors: Gilead Sciences
Tizona Therapeutics, Inc. raised $43M on March 8, 2016
Investors: Astellas Venture Capital L.L.C., Abingworth, Lightstone Ventures, MPM Capital, Canaan and InterWest Partners
Tizona Therapeutics, Inc. raised $27M on January 10, 2016
Investors: Astellas Venture Capital L.L.C., MPM Capital and InterWest Partners